Literature DB >> 21942475

Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization.

Basant Malik1, Amit K Goyal, T S Markandeywar, Goutam Rath, Foziyah Zakir, Suresh P Vyas.   

Abstract

Present work was envisaged to develop novel M-cell targeted polymeric particles that are capable of protecting the antigen from harsh gastric conditions. Ulex europaeus agglutinin (UEA-1) lectin was anchored for selective delivery of antigen to gut-associated lymphoid tissue (GALT). In the present investigation, chitosan nanoparticles were prepared by ionic gelation followed by antigen (bovine serum albumin, BSA) adsorption. Developed nanoparticles were further coated by UEA-1 lectin conjugated alginate and characterized for size, shape, zeta-potential, entrapment efficiency, and in vitro release. The immunological response of the developed system were performed in Balb/c mice and compared with aluminium hydroxide gel-based conventional vaccine. Results indicated that immunization with UEA-1 lectin conjugated alginate-coated particles induces efficient systemic as well as mucosal immune responses against BSA compared to other formulations. Aluminium-based vaccine dominated throughout the study, while failed in case of mucosal antibody. Additionally, IgG1 and IgG2a isotypes were determined to confirm the TH1/TH2 mixed immune response. The developed formulation exhibited superior systemic response along with dominating mucosal immunity. These data demonstrate the potential of UEA-alginate-coated nanoparticles as effective delivery system via oral route.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21942475     DOI: 10.3109/1061186X.2011.611516

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  15 in total

1.  Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.

Authors:  Junyong Zhao; Xiaoyu Li; Qifeng Luo; Lei Xu; Lei Chen; Li Chai; Yixiang Huang; Lin Fang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 2.  Roles of M cells in infection and mucosal vaccines.

Authors:  Miao Wang; Zeqian Gao; Zhongwang Zhang; Li Pan; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Mucosal vaccine delivery: Current state and a pediatric perspective.

Authors:  Akhilesh Kumar Shakya; Mohammed Y E Chowdhury; Wenqian Tao; Harvinder Singh Gill
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

Review 4.  Demystifying particle-based oral vaccines.

Authors:  Pedro Gonzalez-Cruz; Harvinder Singh Gill
Journal:  Expert Opin Drug Deliv       Date:  2021-07-06       Impact factor: 8.129

Review 5.  Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Authors:  Shujing Wang; Huiqin Liu; Xinyi Zhang; Feng Qian
Journal:  Protein Cell       Date:  2015-05-06       Impact factor: 14.870

Review 6.  Biomimetic strategies for targeted nanoparticle delivery.

Authors:  Diana Dehaini; Ronnie H Fang; Liangfang Zhang
Journal:  Bioeng Transl Med       Date:  2016-05-27

Review 7.  Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body.

Authors:  Régis Stentz; Ana L Carvalho; Emily J Jones; Simon R Carding
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

Review 8.  Needle-Free Immunization with Chitosan-Based Systems.

Authors:  Bijay Singh; Sushila Maharjan; Princy Sindurakar; Ki-Hyun Cho; Yun-Jaie Choi; Chong-Su Cho
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

Review 9.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

Review 10.  Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.

Authors:  Alejandro Sosnik
Journal:  ISRN Pharm       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.